Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2013 2
2019 3
2021 5
2022 2
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
[Academia-Industry Alliance: Recent Trend].
Nakagawa A, Perl L, Lee J, Harada-Shoji N, Ota C, Shiga T, Sunami S, Niizuma K, Endo H, Harigae H, Tominaga T. Nakagawa A, et al. Among authors: harada shoji n. No Shinkei Geka. 2024 Jan;52(1):213-225. doi: 10.11477/mf.1436204899. No Shinkei Geka. 2024. PMID: 38246689 Japanese.
Usefulness of cardiac magnetic resonance for early detection of cancer therapeutics-related cardiac dysfunction in breast cancer patients.
Terui Y, Sugimura K, Ota H, Tada H, Nochioka K, Sato H, Katsuta Y, Fujiwara J, Harada-Shoji N, Sato-Tadano A, Morita Y, Sun W, Higuchi S, Tatebe S, Fukui S, Miyamichi-Yamamoto S, Suzuki H, Yaoita N, Kikuchi N, Sakota M, Miyata S, Sakata Y, Ishida T, Takase K, Yasuda S, Shimokawa H. Terui Y, et al. Among authors: harada shoji n. Int J Cardiol. 2023 Jan 15;371:472-479. doi: 10.1016/j.ijcard.2022.09.025. Epub 2022 Sep 15. Int J Cardiol. 2023. PMID: 36115441
Bird's eye view analysis of in situ cholesterol metabolic pathways in breast cancer patients and its clinicopathological significance in their subtypes.
Kosaka S, Miyashita M, McNamala K, Nomura M, Shima H, Kawai M, Sato I, Harada-Shoji N, Ishida T, Choi MH, Sasano H. Kosaka S, et al. Among authors: harada shoji n. J Steroid Biochem Mol Biol. 2022 Jul;221:106103. doi: 10.1016/j.jsbmb.2022.106103. Epub 2022 Mar 31. J Steroid Biochem Mol Biol. 2022. PMID: 35367370
Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer.
Shindo H, Harada-Shoji N, Ebata A, Sato M, Soga T, Miyashita M, Tada H, Kawai M, Kosaka S, Onuki K, Usami S, Furumoto S, Hayashi S, Abe T, Suzuki T, Ishida T, Sasano H. Shindo H, et al. Among authors: harada shoji n. Cancers (Basel). 2021 Aug 30;13(17):4375. doi: 10.3390/cancers13174375. Cancers (Basel). 2021. PMID: 34503187 Free PMC article.
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma.
Nakagawa S, Miyashita M, Maeda I, Goda A, Tada H, Amari M, Kojima Y, Tsugawa K, Ohi Y, Sagara Y, Sato M, Ebata A, Harada-Shoji N, Suzuki T, Nakanishi M, Ohta T, Ishida T. Nakagawa S, et al. Among authors: harada shoji n. Breast Cancer Res Treat. 2024 Apr;204(3):453-463. doi: 10.1007/s10549-023-07209-2. Epub 2024 Jan 5. Breast Cancer Res Treat. 2024. PMID: 38180699 Free PMC article.
17 results